Sign in

You're signed outSign in or to get full access.

Michael Taggart

Vice President at abrdn World Healthcare Fund
Executive

About Michael Taggart

Michael Taggart serves as Vice President of abrdn World Healthcare Fund (THW) and other abrdn funds; year of birth 1970; officer since 2023. He is currently a Closed-End Fund Specialist at abrdn Inc.; prior roles include Vice President of Investment Research and Operations at Relative Value Partners (from June 2022), self‑employed after leaving Nuveen in November 2020 where he served as Vice President of Closed‑End Fund Product Strategy (November 2013–November 2020) . Fund documents do not disclose officer-level performance metrics or pay‑for‑performance structures; officers are employees of abrdn and receive no compensation from the Funds .

Past Roles

OrganizationRoleYears (as disclosed)Strategic Impact / Focus
abrdn Inc.Closed‑End Fund SpecialistSince 2023 Product/strategy specialist for closed‑end funds; serves as Fund officer (Vice President)
Relative Value Partners, LLCVice President, Investment Research & OperationsFrom June 2022 Investment research and operations leadership for fund strategies
NuveenVice President, Closed‑End Fund Product StrategyNov 2013–Nov 2020 Closed‑end fund product strategy across Nuveen’s CEF platform
Self‑employedConsultant/IndependentAfter Nov 2020 until joining RVP (June 2022) Independent work following Nuveen tenure

Fixed Compensation

All officers of the Funds are employees of and are compensated by abrdn Inc. or an affiliate. None of the Funds’ executive officers who are also officers of abrdn Inc. received any compensation from any Fund for the fiscal year ended September 30, 2024. None of the Funds have any bonus, profit sharing, pension or retirement plans .

ComponentFund-Paid AmountSource
Base salary$0 Officers are compensated by abrdn Inc., not by THW
Target bonus$0 Funds do not have bonus/profit sharing plans
Pension/retirementNone Funds do not have pension/retirement plans

Performance Compensation

Metric/Plan FeatureDisclosure
Incentive structure (RSUs, PSUs, options)Not disclosed at the Fund level; officers are paid by abrdn Inc., and Fund documents do not detail abrdn’s officer incentive plans
Performance metrics tied to pay (e.g., TSR, EBITDA)Not disclosed in THW proxy for officers
Clawbacks, tax gross‑upsNot disclosed in THW proxy for officers

Equity Ownership & Alignment

MetricAs ofAmount/StatusNotes
Beneficial ownership (THW common)Mar 11, 20250 sharesForm 3 states “No securities are beneficially owned”
Ownership % of shares outstandingMar 11, 20250%Derived from zero shares reported
Options (exercisable/unexercisable)Mar 11, 2025None reportedNo derivative holdings disclosed on Form 3
RSUs/PSUs (vested/unvested)Mar 11, 2025None reportedNo equity awards disclosed in Fund filings
Shares pledged as collateralMar 11, 2025Not disclosedForm 3 reports no holdings
Ownership guidelines/complianceFY 2024/FY 2025Not disclosed Fund proxy does not set officer ownership guidelines

Employment Terms

TermDisclosure
Officer title/roleVice President (officer of THW and other funds)
Appointment/tenureOfficers are appointed annually at a meeting of the Fund Board; officers hold their positions until a successor is duly elected and qualifies
Employerabrdn Inc. (officers are employees of abrdn Inc. or an affiliate)
Compensation payerabrdn Inc.; no Fund‑paid compensation to officers
Severance/change‑of‑controlNot detailed in Fund proxy for officers; Fund documents focus on advisory agreement terms, not officer severance
Non‑compete/non‑solicit/garden leaveNot disclosed in Fund proxy for officers
Section 16 complianceTaggart filed Form 3 reporting no holdings; FY 2024 proxy notes specific late filings for other individuals, with no mention of Taggart
Power of Attorney for SEC filingsExecuted June 11, 2024 authorizing attorneys‑in‑fact to make Section 16 filings

Investment Implications

  • Pay-for-performance transparency is limited at the Fund level: officers are paid by abrdn Inc., and the Fund discloses no officer‑level cash/equity mix, targets, or payout curves; THW bears no direct officer compensation expense, reducing Fund‑level pay alignment concerns but limiting visibility into incentives .
  • Alignment via ownership appears minimal at present: Taggart reported zero THW beneficial ownership on Form 3 (Mar 11, 2025), implying no current insider ownership‑driven selling pressure; continue to monitor future Forms 4/5 for any changes .
  • Retention risk and incentive levers reside within abrdn’s internal employment terms, not Fund contracts; officers are appointed annually and serve until successors are elected, suggesting role continuity is Board‑driven rather than governed by Fund‑level employment agreements .
  • Governance/compliance signal: execution of a standing Power of Attorney for Section 16 filings indicates procedural readiness for timely reporting; FY 2024 proxy notes late filings for other individuals but does not cite Taggart, which is neutral to positive from a compliance standpoint .